%0 Journal Article
%A Guillen-Del-Castillo, Alfredo
%A Meseguer, Manuel López
%A Fonollosa-Pla, Vicent
%A Gimenez, Berta Sáez
%A Colunga-Argüelles, Dolores
%A Revilla-Lopez, Eva
%A Rubio-Rivas, Manuel
%A Ropero, Maria Jose Cristo
%A Argibay, Ana
%A Barbera, Joan Albert
%A Salas, Xavier Pla
%A Meñaca, Amaya Martínez
%A Vuelta, Ana Belen Madroñero
%A Padron, Antonio Lara
%A Comet, Luis Saez
%A Morera, Juan Antonio Domingo
%A Gonzalez-Echavarri, Cristina
%A Mombiela, Teresa
%A Ortego-Centeno, Norberto
%A Gonzalez, Manuela Marín
%A Tolosa-Vilella, Carles
%A Blanco, Isabel
%A Subias, Pilar Escribano
%A Simeon-Aznar, Carmen Pilar
%T Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension.
%D 2022
%U http://hdl.handle.net/10668/19596
%X To assess severity markers and outcomes of patients with systemic sclerosis (SSc) with or without pulmonary arterial hypertension (PAH-SSc/non-PAH-SSc), and the impact of interstitial lung disease (ILD) on PAH-SSc. Non-PAH-SSc patients from the Spanish SSc registry and PAH-SSc patients from the Spanish PAH registry were included. A total of 364 PAH-SSc and 1589 non-PAH-SSc patients were included. PAH-SSc patients had worse NYHA-functional class (NYHA-FC), worse forced vital capacity (FVC) (81.2 ± 20.6% vs 93.6 ± 20.6%, P 
%~